Huapont Life Sciences Co.,Ltd. (SHE:002004)

Huapont Life Sciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021
Cash & Equivalents	3,669	3,290	3,783	4,187	4,386	4,122
Short-Term Investments	888.5	1,556	1,197	799.5	605.52	-
Trading Asset Securities	846.94	653.87	630.28	706.29	1,030	862.27
Cash & Short-Term Investments	5,405	5,500	5,610	5,692	6,022	4,985
Cash Growth	-0.98%	-1.97%	-1.44%	-5.47%	20.81%	6.30%
Accounts Receivable	2,962	2,554	2,048	2,294	2,676	2,196
Other Receivables	568.55	579	681.23	583.37	666.99	401.89
Receivables	3,531	3,133	2,729	2,877	3,343	2,598
Inventory	2,172	2,253	2,675	2,536	2,402	1,951
Prepaid Expenses	-	-	-	3.88	14.94	-
Other Current Assets	430.68	390.25	373.77	445.45	531.85	1,269
Total Current Assets	11,539	11,277	11,387	11,554	12,314	10,803
Property, Plant & Equipment	9,806	9,925	10,051	8,920	7,973	7,922
Long-Term Investments	2,523	2,474	2,894	2,940	2,534	2,605
Goodwill	2,032	2,032	2,740	2,948	3,440	3,465
Other Intangible Assets	1,566	1,526	1,599	1,733	1,724	1,643
Long-Term Deferred Tax Assets	558.73	525.93	434.04	342.15	266.23	354.99
Long-Term Deferred Charges	510.68	575.07	540.53	558.56	570.14	323.71
Other Long-Term Assets	1,119	1,116	1,082	1,033	1,218	1,147
Total Assets	29,654	29,450	30,727	30,029	30,040	28,263
Accounts Payable	2,098	2,266	2,703	2,375	2,439	1,759
Accrued Expenses	1,656	403.62	398.82	1,728	1,556	329.25
Short-Term Debt	3,271	3,561	4,666	4,576	5,493	7,409
Current Portion of Long-Term Debt	1,904	2,318	1,016	1,678	1,192	-
Current Portion of Leases	7.94	13.98	12.62	9.52	9.44	-
Current Income Taxes Payable	118.74	159.24	121.68	245.78	170.38	125.24
Current Unearned Revenue	111.85	225.51	201.39	304.6	383.17	284.55
Other Current Liabilities	212.77	1,468	1,515	193.96	146.13	1,816
Total Current Liabilities	9,380	10,415	10,634	11,112	11,389	11,723
Long-Term Debt	3,694	2,943	2,884	1,742	2,222	1,839
Long-Term Leases	50.99	53.42	47.62	41.9	51.62	34.87
Long-Term Unearned Revenue	268.6	266.87	271.23	278.21	258.13	224.94
Long-Term Deferred Tax Liabilities	103.08	104.62	111.64	109.84	103.4	108.31
Other Long-Term Liabilities	193.84	193.84	193.95	194.63	196.68	196.8
Total Liabilities	13,691	13,977	14,143	13,478	14,221	14,126
Common Stock	1,980	1,980	1,980	1,980	1,980	1,980
Additional Paid-In Capital	5,310	5,304	5,290	5,249	5,214	4,885
Retained Earnings	2,572	2,183	2,920	3,050	3,089	2,857
Treasury Stock	-30	-30	-	-	-	-
Comprehensive Income & Other	-83.47	-100.67	-84.95	-87.55	-176.15	-92.77
Total Common Equity	9,748	9,337	10,105	10,192	10,107	9,629
Minority Interest	6,215	6,136	6,480	6,359	5,712	4,507
Shareholders' Equity	15,964	15,473	16,585	16,551	15,819	14,137
Total Liabilities & Equity	29,654	29,450	30,727	30,029	30,040	28,263
Total Debt	8,928	8,890	8,626	8,048	8,968	9,283
Net Cash (Debt)	-3,523	-3,390	-3,016	-2,355	-2,946	-4,298
Net Cash Per Share	-1.79	-1.72	-1.52	-1.19	-1.49	-2.18
Filing Date Shares Outstanding	1,973	1,973	1,976	1,980	1,980	1,980
Total Common Shares Outstanding	1,973	1,973	1,980	1,980	1,980	1,980
Working Capital	2,159	861.64	753.65	442.59	924.82	-919.78
Book Value Per Share	4.94	4.73	5.10	5.15	5.10	4.86
Tangible Book Value	6,150	5,779	5,766	5,511	4,943	4,522
Tangible Book Value Per Share	3.12	2.93	2.91	2.78	2.50	2.28
Buildings	6,037	5,919	5,626	5,120	4,570	4,509
Machinery	8,479	8,462	7,632	6,765	6,051	5,492
Construction In Progress	1,294	1,154	1,869	1,434	1,464	1,532

Source: S&P Global Market Intelligence. Standard template. Financial Sources.